LIA
SUPN icon

LS Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

LS Investment Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,810
Closed -$43K – 1372
2020
Q2 		$43K Hold
1,810
– – ﹤0.01% 1215
2020
Q1 		$33K Hold
1,810
– – ﹤0.01% 1221
2019
Q4 		$43K Sell
1,810
-4,237
-70% -$103K ﹤0.01% 1353
2019
Q3 		$166K Hold
6,047
– – 0.01% 853
2019
Q2 		$200K Buy
6,047
+71
+1% +$2.43K 0.01% 780
2019
Q1 		$209K Buy
5,976
+543
+10% +$20.2K 0.01% 772
2018
Q4 		$180K Sell
5,433
-492
-8% -$21.2K 0.01% 783
2018
Q3 		$298K Sell
5,925
-1,059
-15% -$52.3K 0.02% 690
2018
Q2 		$418K Sell
6,984
-30
-0.4% -$1.55K 0.03% 575
2018
Q1 		$321K Sell
7,014
-2
-0% -$83 0.02% 660
2017
Q4 		$280K Sell
7,016
-2,132
-23% -$84.2K 0.02% 735
2017
Q3 		$366K Buy
9,148
+2,162
+31% +$93.6K 0.02% 669
2017
Q2 		$301K Sell
6,986
-68
-1% -$2.42K 0.02% 740
2017
Q1 		$221K Buy
7,054
+4,943
+234% +$132K 0.01% 805
2016
Q4 		$53K Hold
2,111
– – ﹤0.01% 1236
2016
Q3 		$52K Buy
2,111
+677
+47% +$15.3K ﹤0.01% 1203
2016
Q2 		$29K Buy
1,434
+234
+20% +$4.15K ﹤0.01% 1397
2016
Q1 		$18K Hold
1,200
– – ﹤0.01% 1512
2015
Q4 		$16K Hold
1,200
– – ﹤0.01% 1552
2015
Q3 		$17K Buy
1,200
+114
+10% +$2.12K ﹤0.01% 1524
2015
Q2 		$18K Buy
+1,086
New +$15.5K ﹤0.01% 1540

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

LS Investment Advisors's SUPN Position: Q3 2020 in Review

LS Investment Advisors sold out of Supernus Pharmaceuticals (SUPN) in Q3 2020, closing a stake of 1,810 shares — an estimated $43K sold.

LS Investment Advisors first reported a position in SUPN in Q2 2015 and held it in 21 quarters. The position peaked at $418K in Q2 2018. 209 funds tracked by Wall St. Rank hold SUPN as of Q3 2020.

  • LS Investment Advisors reported no remaining Supernus Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 1,810 Supernus Pharmaceuticals shares in Q3 2020, an estimated $43K.
  • LS Investment Advisors first reported a position in Supernus Pharmaceuticals in Q2 2015 and held it in 21 quarters.
  • LS Investment Advisors's Supernus Pharmaceuticals position peaked at $418K in Q2 2018.
  • 209 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.